Medication Guide - 6/5/2026

Medication guides are FDA- approved documents that address issues that are specific to particular drugs, and can help patients avoid serious adverse events (side effects). This database does not include Medication Guides for FDA-approved allergenic or cellular/tissue products (see FDA Online Label Repository or DailyMed for these Medication Guides). More

Drug Name	Active Ingredient	Form;Route	Appl. No.	Company	Date
Afrezza	Insulin Recombinant Human	POWDER;INHALATION	022472	MANNKIND	05/28/2026
Columvi	Glofitamab-Gxbm	INJECTABLE;INTRAVENOUS	761309	GENETECH	05/28/2026
Imfinzi	Durvalumab	INJECTABLE;INJECTION	761069	ASTRAZENECA UK LTD	05/28/2026
Tremfya	Guselkumab	INJECTABLE;INJECTION	761061	JANSSEN BIOTECH	05/28/2026

Manage Subscriptions | Unsubscribe All | Help


This email was sent to Esdek@podam.pl using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration · 10903 New Hampshire Ave · Silver Spring, MD · 20993-0002 · 1-888-INFO-FDA